Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials

Myeloid's cell therapy harnesses the innate capabilities of myeloid lineage cells to fight cancer Scientific founders include world-renowned cell therapy & cancer experts Ronald Vale, Ph.D. and Siddhartha Mukherjee, M.D., D.Phil. Co-Founded by Thomas... Biopharmaceuticals, Oncology, Venture Capital Myeloid Therapeutics, lymphoma, glioblastoma
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news